scispace - formally typeset
T

Takahiro Suzuki

Researcher at Nihon University

Publications -  162
Citations -  1463

Takahiro Suzuki is an academic researcher from Nihon University. The author has contributed to research in topics: Rocuronium & Medicine. The author has an hindex of 16, co-authored 137 publications receiving 1228 citations. Previous affiliations of Takahiro Suzuki include Cornell University.

Papers
More filters
Journal ArticleDOI

Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.

TL;DR: This study demonstrated that the risk of TOFR <0.9 after tracheal extubation after sugammadex remains as high as 9.4% in a clinical setting in which neuromuscular monitoring (objective or subjective) was not used.
Journal ArticleDOI

Functional annotation of human long noncoding RNAs via molecular phenotyping

Jordan A. Ramilowski, +117 more
- 27 Jul 2020 - 
TL;DR: The largest-to-date lncRNA knockdown data set with molecular phenotyping is disseminated for further exploration and functional roles for ZNF213-AS1 and lnc-KHDC3L-2 are highlighted.
Journal ArticleDOI

Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block

TL;DR: A TOF ratio of 0.9 displayed postoperatively on AMG does not always represent adequate recovery of neuromuscular function and should be normalized by baseline value to reliably detect residual paralysis.
Journal ArticleDOI

Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients

TL;DR: Sugammadex can adequately restore neuromuscular function in older patients, although a longer time is required to recover from profound rocuronium-induced neuromUScular block than in younger patients.
Journal ArticleDOI

Inhibitory effects of water-soluble low-molecular-weight β-(1,3–1,6) d-glucan purified from Aureobasidium pullulans GM-NH-1A1 strain on food allergic reactions in mice

TL;DR: Findings suggest that anti-food allergic action of LMW-beta-Glucan may be due to the inducing IFN-gamma production in the small intestine and splenocytes of the OVA-sensitized mice.